Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes

Clinical trial NCT01576328 · COMPLETED

Trial details

NCT number: NCT01576328
Sponsor: Mesoblast, Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2012-04-01
Primary completion: 2013-10-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.